Dextromethorphan Hydrobromide And Quinidine Sulphate Capsule
Product Images NDC 84677-067

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dextromethorphan Hydrobromide And Quinidine Sulphate (NDC 84677-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

84677-067-60ol.jpg (84677 067 60ol)

84677-067-60ol.jpg (84677 067 60ol)
Label for Dextromethorphan Hydrobromide and Quinidine Sulfate capsules, 20 mg / 10 mg strength, in a 60-capsule package. The label includes the NDC 84677-067-60, manufacturer Golden State Medical Supply, and storage instructions. It indicates the product is prescription only and child-resistant packaging is used.*
FDA Label Image

Dextro Hbr Structural Formula (Dextro Hbr Structural Formula)

Dextro Hbr Structural Formula (Dextro Hbr Structural Formula)
Chemical structure of Dextromethorphan Hydrobromide, showing a multi-ring structure with a methoxy group attached to a benzene ring, and annotations indicating hydrobromide and water molecules.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
Line graph comparing mean change from baseline in laughing and crying episodes over time between Dextromethorphan/quinidine 20/10 mg and placebo groups. The x-axis shows visits from baseline to day 84, while the y-axis represents mean change. The treatment group shows a greater decrease compared to placebo, marked with statistical significance (p < 0.05) at multiple time points.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph comparing least square mean change from baseline CNS-LS scores over time between Dextromethorphan/quinidine 20/10 mg and placebo. The x-axis shows time points from baseline (Visit 1) to Day 84 (Visit 5), and the y-axis shows score change values. The Dextromethorphan/quinidine group shows a greater decrease in scores over time compared to placebo, with statistically significant differences marked at Days 57 and 84.*
FDA Label Image

Quinidine Sulfate Structural Formula (Quinidine Sulfate Structural Formula)

Quinidine Sulfate Structural Formula (Quinidine Sulfate Structural Formula)
Chemical structure of Dextromethorphan Hydrobromide and Quinidine Sulphate, showing the molecular arrangement with carbon, hydrogen, nitrogen, and oxygen atoms including a methoxy group and a double bond section, as well as sulfate and water molecules (H2SO4 and H2O) in the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.